VIENNA — The investigational interleukin (IL)-17 inhibitor izokibep hit its mark when it came to improving overall disease activity in people with active psoriatic arthritis (PsA) […]

When he completed his fellowship at Fox Chase Cancer Center in Philadelphia, Moshe Chasky, MD, joined a small five-person practice that rented space from the city’s […]

While rates of most other cancers have declined or plateaued, the incidence and mortality rate of endometrial cancer continue to rise.[1] The landscape of endometrial cancer […]

Emergencies happen anywhere, anytime, and sometimes, medical professionals find themselves in situations where they are the only ones who can help. Is There a Doctor in the […]

Patients with atopic dermatitis (AD) had a lower risk for major adverse cardiovascular events (MACE) than the general population, and this risk was significantly lower than […]

VIENNA — When it comes to improving joint and skin symptoms in people with psoriatic arthritis (PsA), real-world data suggest that it may not matter too […]

VIENNA — The highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients with active rheumatoid arthritis to meet American College of Rheumatology (ACR) […]

Your day begins before sunrise when you arrive at your designated floor and are greeted with a flurry of activity — from nurses bustling around to […]